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Image 1. Iberian ibex infested by Sarcoptes scabiei next to 
a healthy one in Sierra Nevada Natural Park
Objective:
Since the creation of the reservoir El Toril 25 years ago, only one protocol addressed to control sarcoptic
mange has been stablished. The aim of this study is to establish a health surveillance program including
the principal disease that affects or could potentially affect the Iberian ibex, taking into account that the
epidemiology and pathology of this disease in captive conditions could defer from those observed in wild
populations. Two different situations have been considered: one for the quarantine of new animals and
another for the ones maintained in the enclosure.
Background:
The Iberian Ibex (Capra pyrenaica) is an endemic specie of the Iberian Peninsula and one of its most
emblematic animals. In the last few years several outbreaks of sarcoptic mange have seriously
threatened some of its most important populations, including the one in Sierra Nevada Natural Park. This
motivated the creation of enclosure-reservoirs of Iberian ibex. Therefore, in case of new massive
mortalities, a stock of healthy individuals could be used for reintroduction or repopulation.
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QUARANTINE ENCLOSURE
Disease Diagnosis Treatment Diagnosis Treatment
Sarcoptic
mange




ELISA  and visual inspection Ivermectin (IVOMEC GOLD®) to all animals
Tuberculosis
Tuberculin test. Confirm 
positives with post-mortem
PCR
Do not enter positives
Annual tuberculin test if free enclosure and 
every two months if positive. Confirm with 
post-mortem PCR.
Sacrifice positives
Brucellosis Rose Bengal test Do not enter positives
Annual Rose Bengal test if free enclosure 
and every three months if positive.
Sacrifice positives
Blue tongue
ELISA. Confirm positives 
with PCR
Do not enter positives Annual ELISA. Confirm positives with PCR Positives eliminatio
Mycoplasmas
PCR M. agalactiae, M. 
mycoides and M. 
conjunctivae
Free enclosure: Do not enter positives 
Positive enclosure: Treat positives with 
long-term antibiotic: tulathromycine
(Draxxin®)
PCR M. agalactiae, M. mycoides and M. 
conjunctivae in free enclosure or eradication 
program. If not ELISA.
Eradication program: Positives elimination and prophylactic 
antibiotic to all animals tulathromycine (Draxxin®). No 
eradication program: prophylactic antibiotic to al animals.
Caseous
lymphadenitis
ELISA and visual 
inspection
Free enclosure: Do not enter positives
Positive enclosure: Treat positives  
(Penicillin), add autovaccine if 
outbreak
ELISA and visual inspection
Eradication program: positives elimination, autovaccine and 
enclosure disinfection. No eradication program: treat 
positives (Penicillin) or to all animals and add autovaccine if 
outbreak
Pasteurelosis Management measures Management measures
Chlamydophila
Complement Fixation test. 
Confirm positives with PCR
Free enclosure: Do not enter positives. 
Positive enclosure: antibiotic treatment 
to positives
Annual complement fixation test. Confirm 
positives with PCR
Prophylactic antibiotic treatment to all animals and isolation 
of positives with clinic. 
Johne’s
disease
Nested PCR if positive 
enclosure.
Culture if free enclosure
Free enclosure: Do not enter positives.
Positive enclosure: Do not enter 
positive for a different strain
Free enclosures or no eradication program: 
Annual ELISA and PCR confirmation 
Eradication program: ELISA or culture
Eradication program: elimination of positives to culture or >2 
consecutive ELISA.
No eradication program sacrifice positives with severe clinic.
Q Fever
ELISA. Confirm positives 
with PCR
Treat positives with long-term 
oxytetracycline (Duramycin 300®). 
Vaccination if vaccination program.
ELISA and positives confirmation with PCR if 
no current vaccination program
Annual revaccination if vaccination program.
Positive enclosure: Positives treatment with oxytetracycline
if no current vaccination program
Babesia ovis
ELISA and blood smear of 
anaemic animals
Positives treatment with Imidocarb
(Imidox 120®)
ELISA and blood smear of anaemic animals Imidocarb as in quarantine
a b c
Image 4. Iberian ibexes from El Toril infected by different pathogens  a) Sarcoptic mange b) Caseous lymphadenitis c) 
infectious keratoconjunctivitis
Image 3. Aerian view of the enclosure-reservoir El 
Toril and detail of its corral-trap and quarantines
Image 2. Distribution of Iberian Ibex in Spain (MAGRAMA)
Conclusions
By the study of the seroprevalence and outbreaks of
different infectious diseases in Iberian ibex or other
wild ungulate species and domestic goat (Capra
aegagrus hircus) when those were not available, 11
diseases have been considered in the protocol.
Different protocols have been stablished for each of
them as seen in Table 1.
A quarantine period of 30 days minimum and two
annual managements are recommended.
Table 1. Resume of the health surveillance program for quarantines and the enclosure
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